Detection and Classification of Immature Leukocytes for Diagnosis of Acute Myeloid Leukemia Using Random Forest Algorithm.
acute myeloid leukemia
computer-aided diagnosis
cytomorphology
feature importance
immature leukocyte
machine learning
peripheral blood smear
random forest
segmentation
Journal
Bioengineering (Basel, Switzerland)
ISSN: 2306-5354
Titre abrégé: Bioengineering (Basel)
Pays: Switzerland
ID NLM: 101676056
Informations de publication
Date de publication:
01 Oct 2020
01 Oct 2020
Historique:
received:
20
08
2020
revised:
18
09
2020
accepted:
29
09
2020
entrez:
6
10
2020
pubmed:
7
10
2020
medline:
7
10
2020
Statut:
epublish
Résumé
Acute myeloid leukemia (AML) is a fatal blood cancer that progresses rapidly and hinders the function of blood cells and the immune system. The current AML diagnostic method, a manual examination of the peripheral blood smear, is time consuming, labor intensive, and suffers from considerable inter-observer variation. Herein, a machine learning model to detect and classify immature leukocytes for efficient diagnosis of AML is presented. Images of leukocytes in AML patients and healthy controls were obtained from a publicly available dataset in The Cancer Imaging Archive. Image format conversion, multi-Otsu thresholding, and morphological operations were used for segmentation of the nucleus and cytoplasm. From each image, 16 features were extracted, two of which are new nucleus color features proposed in this study. A random forest algorithm was trained for the detection and classification of immature leukocytes. The model achieved 92.99% accuracy for detection and 93.45% accuracy for classification of immature leukocytes into four types. Precision values for each class were above 65%, which is an improvement on the current state of art. Based on Gini importance, the nucleus to cytoplasm area ratio was a discriminative feature for both detection and classification, while the two proposed features were shown to be significant for classification. The proposed model can be used as a support tool for the diagnosis of AML, and the features calculated to be most important serve as a baseline for future research.
Identifiants
pubmed: 33019619
pii: bioengineering7040120
doi: 10.3390/bioengineering7040120
pmc: PMC7711527
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Leuk Res. 2018 Jun;69:54-59
pubmed: 29656215
EXCLI J. 2019 Jun 14;18:382-404
pubmed: 31338009
J Clin Med. 2016 Mar 05;5(3):
pubmed: 26959069
J Pathol Inform. 2013 Mar 30;4(Suppl):S15
pubmed: 23766937
BMC Hematol. 2013 Oct 31;13(1):9
pubmed: 24238148
J Med Signals Sens. 2015 Jan-Mar;5(1):49-58
pubmed: 25709941
J Clin Lab Anal. 2017 Mar;31(2):
pubmed: 27427422
Genes Cancer. 2011 Feb;2(2):95-107
pubmed: 21779483
Biomed Eng Online. 2015 Jun 30;14:63
pubmed: 26123131
J Digit Imaging. 2013 Dec;26(6):1045-57
pubmed: 23884657
Comput Math Methods Med. 2018 Feb 28;2018:6125289
pubmed: 29681996
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818802789
pubmed: 30261827
PeerJ. 2014 Jun 19;2:e453
pubmed: 25024921
J Med Signals Sens. 2016 Jul-Sep;6(3):183-93
pubmed: 27563575
Diagnostics (Basel). 2019 Aug 25;9(3):
pubmed: 31450720
BMC Med Inform Decis Mak. 2011 Jul 29;11:51
pubmed: 21801360
Int J Pediatr. 2012;2012:129707
pubmed: 22518173
Int J Lab Hematol. 2019 Dec;41(6):717-725
pubmed: 31498973